Onvatilimab (JNJ-61610588) is a human IgG1 kappa-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody with antitumor activity, potentially used for treating advanced head and neck cancers.
Purity:
>95%
CAS Number:
[1969313-51-6]
Target:
PD-1/PD-L1|||Others
* VAT and and shipping costs not included. Errors and price changes excepted